Low levels of miR320 were associated with advanced stage, LNM, and poorer OS in BC patients,195 as well as serum exosomal miR‐940 levels reflecting the presence of lymph node metastases and EGFR type 2 status, which may be a biomarker for metastasis in breast cancer.196. The gene discussed is EGFR; the disease is breast cancer.